Pictet North America Advisors Sa Abb Vie Inc. Transaction History

Pictet North America Advisors Sa

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$159.82 - $182.1 $1.27 Million - $1.44 Million	7,932 New	7,932 $1.44 Billion
Q4 2020 Feb 10, 2021	SELL	$80.49 - $108.67 $2.42 Million - $3.27 Million	-30,047 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$85.91 - $100.83 $36,511 - $42,852	425 Added 1.43%	30,047 $2.63 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $222,677 - $297,976	3,035 Added 11.42%	29,622 $2.91 Million
Q1 2020 Apr 30, 2020	BUY	$64.5 - $97.79 $334,174 - $506,649	5,181 Added 24.2%	26,587 $2.03 Million
Q4 2019 Jan 31, 2020	SELL	$72.13 - $90.25 $13,704 - $17,147	-190 Reduced 0.88%	21,406 $1.9 Million
Q3 2019 Nov 08, 2019	BUY	$62.98 - $75.72 $436,766 - $525,118	6,935 Added 47.3%	21,596 $1.64 Million
Q2 2019 Aug 07, 2019	BUY	$65.7 - $83.98 $611,929 - $782,189	9,314 Added 174.19%	14,661 $1.07 Million
Q1 2019 May 01, 2019	BUY	$77.14 - $90.79 $2,005 - $2,360	26 Added 0.49%	5,347 $431,000
Q3 2018 Nov 07, 2018	BUY	$88.91 - $98.84 $12,803 - $14,232	144 Added 2.78%	5,321 $503,000
Q4 2017 Feb 09, 2018	BUY	$89.56 - $98.21 $126,369 - $138,574	1,411 Added 37.47%	5,177 $501,000
Q2 2017 Aug 09, 2017	BUY	N/A	3,766	3,766 $273,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Pictet North America Advisors Sa, based on Form 13F filings with the SEC.

Stay updated on Pictet North America Advisors Sa with notifications on news.